What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Statistics
- Cancer
Health care, Econometrics, Economic evaluation, Management science and Statistics are his primary areas of study.
His Health care research is multidisciplinary, relying on both Cost–benefit analysis and Estimation.
The various areas that Andrew Briggs examines in his Econometrics study include Sensitivity analysis, Uncertainty analysis, Prior probability, Probabilistic analysis of algorithms and Confidence interval.
His Economic evaluation research includes elements of Psychological intervention, MEDLINE, Health economics, Actuarial science and Quality-adjusted life year.
His Management science study combines topics from a wide range of disciplines, such as Research design, Clinical trial and Cost-effectiveness analysis.
His work on Covariate and Parametric statistics as part of general Statistics study is frequently linked to Statistical analysis, bridging the gap between disciplines.
His most cited work include:
- Decision Modelling for Health Economic Evaluation (1658 citations)
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. (1033 citations)
- Primary total hip replacement surgery: a systematic review of outcomes and modelling of cost-effectiveness associated with different prostheses. (947 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Randomized controlled trial, Economic evaluation, Clinical trial and Health care.
His Internal medicine study integrates concerns from other disciplines, such as Surgery, Oncology and Cardiology.
His study ties his expertise on Physical therapy together with the subject of Randomized controlled trial.
His work deals with themes such as Psychological intervention, Cost–benefit analysis, MEDLINE, Health economics and Public relations, which intersect with Economic evaluation.
His research in Cost–benefit analysis focuses on subjects like Cost-effectiveness analysis, which are connected to Econometrics.
He interconnects Actuarial science and Management science in the investigation of issues within Health care.
He most often published in these fields:
- Internal medicine (23.56%)
- Randomized controlled trial (13.26%)
- Economic evaluation (11.69%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (23.56%)
- Randomized controlled trial (13.26%)
- Oncology (10.47%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Randomized controlled trial, Oncology, Clinical trial and COPD.
His research is interdisciplinary, bridging the disciplines of Cardiology and Internal medicine.
He studied Randomized controlled trial and Psychological intervention that intersect with Mental health.
His Clinical trial research integrates issues from Adverse effect and Emergency medicine.
His COPD research is multidisciplinary, incorporating elements of Umeclidinium bromide, Pulmonary disease, Exacerbation, Quality of life and Intensive care medicine.
His Quality of life study combines topics in areas such as Post-hoc analysis, Demography and Health care.
Between 2016 and 2021, his most popular works were:
- Oral versus intravenous antibiotics for bone and joint infection (196 citations)
- 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial. (67 citations)
- 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial. (67 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Statistics
- Cancer
His main research concerns Internal medicine, Randomized controlled trial, Clinical trial, Quality-adjusted life year and Quality of life.
Andrew Briggs combines subjects such as Oncology and Cardiology with his study of Internal medicine.
His studies in Randomized controlled trial integrate themes in fields like Psychological intervention, Cancer, Lung cancer and Weight management.
His studies deal with areas such as Health care, Type 2 diabetes and Emergency medicine as well as Clinical trial.
His work carried out in the field of Quality of life brings together such families of science as Myocardial infarction and Intensive care medicine.
His biological study spans a wide range of topics, including Total cost, Economic evaluation and Remission induction.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
